Valent BioSciences Corporation Achieves ISO 9001:2008 Registration for U.S. Operations

FOR IMMEDIATE RELEASE

LIBERTYVILLE, IL., – July 20, 2010 – Valent BioSciences Corporation, the worldwide leader in the development and commercialization of biorational products for agriculture and public health, has achieved ISO 9001:2008 registration of its U.S. operations, the company announced today.

Valent BioSciences serves customers in more than 90 countries. Its low-risk, environmentally compatible products include key brands such as DiPel®, XenTari®, ProGibb®, Promalin®, ReTain® and VectoBac®. The company also has extensive intellectual property in the emerging area of crop stress management.

“Earning ISO 9001:2008 registration illustrates to customers worldwide our strong commitment to quality at all levels of our organization,” said Mike Donaldson, President and CEO of the company. “Customers want to be confident that they are doing business with an organization that can meet or exceed their needs in a timely manner. Successfully completing the rigorous process required for certification demonstrates that we are continually improving our quality management systems.”

The approval for registration follows the recommendation of the official auditing team, which conducted an extensive audit of Valent BioSciences’ Quality Management System. The audit report specifically noted that “the quality system was well documented and very detailed. It was obvious that the system was being used.”

Donaldson said Valent BioSciences has a strong heritage of quality systems across all of its business operations, which have been the foundation for the consistent quality and performance of its products and the value they have delivered over the decades to its customers.

“As a company specializing in biorational products, the quality in the fermentation, down- stream processing and formulating has been paramount to the sustainability and success of the company,” Donaldson said. “In the future, the Quality Management System will help to continually improve on the products and services we provide to our customers.”

Valent BioSciences received its ISO 9001:2008 registration from Perry Johnson Registrars, Inc., a nationally accredited registrar that performs assessments of quality management systems against requirements of national and international standards for quality.

About Valent BioSciences Corporation
About Valent BioSciences Corporation: Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company. Valent BioSciences is the worldwide leader in the development, manufacturing and commercialization of biorational products, with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
Barbara Wendling
Valent BioSciences Corporation
847-968-4793
Email: barbara.wendling@valentbiosciences.com

Download Press Release

Share:

Related News

Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forest health, has announced that the company began selling biostimulant products directly to its U.S. customer base on October 1.
Sumitomo Chemical Co., Ltd. (SCC), parent company of Valent U.S.A. and Valent Biosciences, today announced a new entity called Valent North America that will provide enterprise business services across the Valent group of companies. 
Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forestry, has announced the promotion of Salman Mir to Executive Vice President and Chief Operating Officer. He will continue reporting to Ted Melnik, Valent BioSciences’ President and Chief Executive Officer.
To promote its industry leadership in biorational and biostimulant product innovation, Valent BioSciences LLC has announced significant investments at several of its key research and development facilities.
Valent BioSciences LLC announced today that it has approved a major expansion of its biorational manufacturing facility in Osage, Iowa, which will meet increasing demand for its biorational products and the introduction of new products requiring more capacity.
The U.S. Environmental Protection Agency recently granted Valent BioSciences LLC an Experimental Use Permit (EUP) to perform further field studies of VBC-60748, a new mosquito space spray targeting pyrethroid-resistant adult mosquitoes.